SCHEMBL403798

SCHEMBL403798

CCOC(=O)c1ccc(O)c(C(=O)OC)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 8/20 0.68
CA2 P00918 8/20 0.68
CA12 O43570 7/20 0.68
CA7 P43166 7/20 0.68
CA9 Q16790 7/20 0.68
CA14 Q9ULX7 7/20 0.68
HSD17B2 P37059 1/20 0.65
KMT2A Q03164 2/20 0.55
XDH P47989 1/20 0.54
ESR1 P03372 1/20 0.54
ESR2 Q92731 1/20 0.54
HPGD P15428 2/20 0.53
HSD17B10 Q99714 2/20 0.53
TSHR P16473 2/20 0.53
KDM4E B2RXH2 2/20 0.50
POLB P06746 1/20 0.50
EGFR P00533 1/20 0.49
LMNA P02545 3/20 0.49
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29403559 0.94 CA12 (0.66) CA1CA2CA12CA7CA9
SCHEMBL10570974 0.92 CA12 (0.74) CA1CA2CA12CA7CA9
SCHEMBL4209898 0.87 CA12 (0.68) CA1CA2CA12CA7CA9
SCHEMBL20996785 0.87 CA12 (0.57) CA1CA2CA12CA7CA9
SCHEMBL403210 0.86 CA12 (0.71) CA1CA2CA12CA7CA9
SCHEMBL6970075 0.85 CA12 (0.70) CA1CA2CA12CA7CA9
SCHEMBL398849 0.85 CA12 (0.70) CA1CA2CA12CA7CA9
SCHEMBL11925424 0.85 CA12 (0.56) CA1CA2CA12CA7CA9
SCHEMBL11925429 0.85 CA12 (0.56) CA1CA2CA12CA7CA9
SCHEMBL23484454 0.82 MAPT (0.53) CA1CA2CA12CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
CN-101056628-B Ester derivatives and medicinal use thereof JAPAN TOBACCO INC 2011-05-25 CN disclosed
CN-101056628-A Ester derivatives and medicinal use thereof JAPAN TOBACCO INC (JP) 2007-10-17 CN disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA CA1 4454/4885CA2 3876/4885CA12 4553/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.